Christchurch, New Zealand Clinical Trials

Adenocarcinoma

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Allergy

Research Site

A clinical trial seeking patients for a research study for the treatment of Allergy

Anemia

Canterbury District Health Board

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Angina

Research Site

Patients are needed to participate in a clinical research study evaluating AMG 334 and Placebo for the treatment of Stable Angina

Asthma

Research Site

Patients are needed to participate in a clinical research study evaluating budesonide/formoterol 'as needed' + budesonide placebo bid and budesonode bid + terbutaline 'as needed' for the treatment of Asthma

Atherosclerosis

Research Site

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Blood Cancer

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bone Diseases

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bone Metastases

Research Site

A clinical research study of Denosumab and Zoledronic acid

COPD (Chronic Obstructive Pulmonary Disease)

1237.19.64002 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Crohn's Disease

Christchurch Hospital

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

Christchurch Hospital

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

Site Reference ID/Investigator# 133293 Updated

A clinical trial to evaluate treatments using ABT-494 and Placebo for patients with Crohn's Disease

Site Reference ID/Investigator# 139027

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Cystic Fibrosis

Canterbury Respiratory Research Group

A Phase 3 clinical study for patients with Cystic Fibrosis

Deep Vein Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Diabetes Mellitus, Type 1

1245.72.64001 Boehringer Ingelheim Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 1

Diabetes Mellitus, Type 2

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Research Site

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Diabetic Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Emphysema

Christchurch Hospital NZ

A clinical research study of Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP) and 0.9% Sodium Chloride for Injection, USP for the treatment of Pulmonary Emphysema in Alpha-1 PI Deficiency

Heart Attack (Myocardial Infarction)

GSK Investigational Site Updated

A Phase 3 clinical study for patients with Acute Coronary Syndrome

Lipid and Diabetes Research Group Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Lipid and Diabetes Research Group Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

View More »

Southern Clinical Trials Shirley Ltd Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Shirley Ltd Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Hemophilia

Research Site

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Hemorrhage

1321.3.64004 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study of idarucizumab to evaluate Hemorrhage

High Blood Pressure (Hypertension)

Research Site

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

High Cholesterol (Hyperlipidemia)

Lipid and Diabetes Research Group Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Lipid and Diabetes Research Group Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Southern Clinical Trials Riccarton Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Shirley Ltd Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

View More »

Southern Clinical Trials Shirley Ltd Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

HIV

Christchurch Clinical Studies Trust

A clinical trial seeking patients for a research study for the treatment of HIV

Hypertriglyceridemia

Research Site

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Idiopathic Pulmonary Fibrosis

Research Site

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

Inflammatory Bowel Disease

Christchurch Hospital

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Influenza

Research Site Updated

A Phase 2 clinical study for patients with Influenza

Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Site Reference ID/Investigator# 134228

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Leukemia

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Neoplasms, Leukemia, Acute Myeloid Leukemia (AML)

Lung Cancer

Christchurch Hospital

Patients are needed to participate in a clinical research study evaluating Custirsen + Docetaxel and Docetaxel for the treatment of Non-Small Cell Lung Cancer

Lung Disease

1237.19.64002 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Lymphocytic Leukemia, Chronic

Research Site Updated

A clinical trial to evaluate treatments using Chlorambucil, GDC-0199 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia

Lymphoma

Research Site Updated

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Multiple Myeloma

Research Site

A clinical research study of Denosumab and Zoledronic acid

Myelofibrosis

Canterbury District Health Board

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Neoplasm Metastasis

Research Site

A clinical research study of Denosumab and Zoledronic acid

Neoplasms

Research Site Updated

A clinical research study of vemurafenib for the treatment of Neoplasms

Research Site

A clinical research study of Denosumab and Zoledronic acid

Nephropathy

Site Reference ID/Investigator# 134228

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Non-Hodgkin's Lymphoma

Research Site Updated

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Non-Small Cell Lung Cancer

Christchurch Hospital

Patients are needed to participate in a clinical research study evaluating Custirsen + Docetaxel and Docetaxel for the treatment of Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 125610

Patients are needed to participate in a clinical research study of veliparib, carboplatin, paclitaxel and placebo to evaluate Squamous Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 132469

Patients are needed to participate in a clinical research study to evaluate Non-squamous Non-small Cell Lung Cancer

Obesity

Research Site

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Pneumonia

Research Site

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

Prostate Cancer

Research Site

Patients are needed to participate in a clinical research study of ARN-509 and Placebo to evaluate Prostatic Neoplasms

Research Site

Patients are needed to participate in a clinical research study of Enzalutamide and Placebo to evaluate Nonmetastatic Castration-Resistant Prostate Cancer

Canterbury Urology Research Trust

A clinical trial to evaluate treatments for patients with Prostate Cancer, Metastatic Prostate Cancer or Castration-resistant Prostate Cancer

Pulmonary Embolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Pulmonary Fibrosis

Research Site

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

Rheumatoid Arthritis

Site Reference ID/Investigator# 139027

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Spinal Cord Injuries

Canterbury District Health Board, Burwood Hospital

A clinical trial to evaluate treatments using Rehabilitation using REX for patients with Spinal Cord Injury

Stomach Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Stroke

Lipid and Diabetes Research Group Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Lipid and Diabetes Research Group Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Southern Clinical Trials Shirley Ltd Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

View More »

Southern Clinical Trials Shirley Ltd Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Thromboembolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ulcerative Colitis

Research Site

A Phase 2/Phase 3 clinical study for patients with Ulcerative Colitis, Moderate to Severe Active Ulcerative Colitis

Christchurch Hospital

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Christchurch Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Site Reference ID/Investigator# 120837

A Phase 3 clinical study for patients with Ulcerative Colitis

Ulcers

Research Site

A Phase 2/Phase 3 clinical study for patients with Ulcerative Colitis, Moderate to Severe Active Ulcerative Colitis

Research Site Updated

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

Christchurch Hospital

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Christchurch Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Site Reference ID/Investigator# 120837

A Phase 3 clinical study for patients with Ulcerative Colitis

Venous Thromboembolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Venous Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)